Edwards Lifesciences Corp at JPMorgan Healthcare Conference (Virtual) Transcript
Welcome back, everyone. I'm Robbie Marcus, the medtech analyst at JPMorgan. Very happy to introduce our next company, Edwards Lifesciences. We're going to have CEO, Mike Mussallem, do the presentation and joining us for Q&A afterwards is CFO, Scott Ullem. Just a little housekeeping, feel free to e-mail me any questions or submit through the conference website, and I'll do my best to ask them.
With that, Mike, I'll turn it over to you and join you in a little bit.
All right. Well, thanks a lot, Robbie, and hello, everybody. I can't believe this is the 40th Annual JPMorgan Healthcare Conference. I think I've been at a great number of these.
So today, we'll be making some forward-looking statements that involves risks. You can find a list of those on our website and on file with the SEC. And we'll also be using some non-GAAP financial measures, which are helpful, and we have reconciliations
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |